Clinical Trials Logo

Clinical Trial Summary

To investigate the effect of radiotherapy on peripheral blood immune cell composition and function in pediatric malignant brain tumor patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04019470
Study type Observational
Source Capital Medical University
Contact
Status Withdrawn
Phase
Start date February 1, 2019
Completion date May 31, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03936465 - Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer Phase 1
Recruiting NCT04738162 - Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors Phase 2
Not yet recruiting NCT06093165 - RE-irradiation of Diffuse MIdline Glioma paTients N/A
Recruiting NCT05298995 - GD2-CAR T Cells for Pediatric Brain Tumours Phase 1
Recruiting NCT05709522 - Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
Recruiting NCT04722237 - Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing N/A
Recruiting NCT06309251 - Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
Recruiting NCT04670016 - HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
Active, not recruiting NCT03086421 - Social Emotional Development in Young Children With Cancer
Active, not recruiting NCT03361033 - Components of Social Functioning in Survivors of Pediatric Brain Tumors
Active, not recruiting NCT04525014 - RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors Phase 1
Recruiting NCT05672043 - Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Recruiting NCT05553899 - Utility of PET-MRI in Surveillance of Paediatric Brain Tumours N/A
Completed NCT03871686 - Promotion of Well-being of Young Adult Brain Cancer Survivors N/A
Active, not recruiting NCT04023669 - Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors Phase 1
Suspended NCT05169944 - Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors Phase 1